Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cerus Corp (CERS)  
$1.84 0.01 (0.54%) as of 4:30 Fri 5/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 167,140,000
Market Cap: 307.54(M)
Last Volume: 407,926 Avg Vol: 1,596,430
52 Week Range: $1.25 - $3.07
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    : 7.6
Insider 6 Months    : 8.6
Insider 3/6 Months : 16
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cerus is a biomedical products company focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The INTERCEPT Blood System, which is based on Co.'s technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Co.'s INTERCEPT Blood System is intented for use with blood components including platelets, plasma and red blood cells. Co. has received U.S. Food and Drug Administration approval for the INTERCEPT Blood System for Cryoprecipitation, which uses Co.'s plasma system to produce INTERCEPT Fibrinogen Complex for the treatment and control of bleeding.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 27,000 37,000 59,500 74,350
Total Buy Value $51,042 $67,242 $106,566 $136,547
Total People Bought 4 5 6 7
Total Buy Transactions 4 5 8 10
Total Shares Sold 370,345 370,345 370,345 575,085
Total Sell Value $759,322 $759,322 $759,322 $1,393,255
Total People Sold 7 7 7 8
Total Sell Transactions 14 14 14 24
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 540
  Page 20 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Glassell Claes Executive Officer and Director   •       •      –    2010-01-06 4 A $0.00 $0 D/D 23,837 200,739     -
   Corash Laurence M Sr. VP & Chief Medical Officer   •       •      –    2009-12-08 4 D $1.88 $5,650 D/D (3,000) 247,558     -
   Corash Laurence M Sr. VP & Chief Medical Officer   •       •      –    2009-12-07 4 D $1.88 $13,175 D/D (7,000) 250,558     -
   Corash Laurence M Sr. VP & Chief Medical Officer   •       •      –    2009-12-04 4 D $1.86 $40,217 D/D (21,644) 257,558     -
   Green Kevin Dennis Chief Accounting OfficerOffice   •       –      –    2009-03-18 3 IO $0.00 $0 D/D 0 14,871     -
   Cassin Bj Director   –       •      –    2008-12-15 4/A B $0.71 $71,160 I/I 100,000 487,921 2.1     -
   Cassin Bj Director   –       •      –    2008-12-15 4 B $0.71 $71,160 I/I 100,000 497,384 2.1     -
   Glassell Claes Executive Officer and Director   •       •      –    2008-12-15 4 B $0.72 $35,775 D/D 50,000 176,902 2.81     -
   Dawson William J Chief Financial Officer   •       –      –    2008-03-17 4 OE $2.05 $205,000 D/D 100,000 156,825     -
   Greenman William Mariner President, Cerus Europe   •       –      –    2008-01-10 4 A $0.00 $0 D/D 4,506 85,490     -
   Ervin Howard G Vice President, Legal Affairs   •       –      –    2008-01-10 4 A $0.00 $0 D/D 4,660 41,901     -
   Glassell Claes Executive Officer and Director   •       •      –    2008-01-10 4 A $0.00 $0 D/D 14,163 126,902     -
   Corash Laurence M Director   –       •      –    2008-01-10 4 A $0.00 $0 D/D 5,469 279,202     -
   Dawson William J Chief Financial Officer   •       –      –    2008-01-10 4 A $0.00 $0 D/D 3,630 56,825     -
   Dawson William J Chief Financial Officer   •       –      –    2007-07-02 4 A $0.00 $0 D/D 25 53,220     -
   Corash Laurence M Director   –       •      –    2007-05-09 4/A B $5.79 $28,952 D/D 5,000 273,733 2.39     -
   Corash Laurence M Director   –       •      –    2007-05-09 4 A $5.79 $28,952 D/D 5,000 273,733     -
   Corash Laurence M Director   –       •      –    2007-05-07 4/A B $6.10 $30,482 D/D 5,000 268,733 2.39     -
   Corash Laurence M Director   –       •      –    2007-05-07 4 A $6.10 $30,482 D/D 5,000 268,733     -
   Glassell Claes Executive Officer and Director   •       •      –    2007-04-13 4 A $0.00 $0 D/D 25 112,764     -
   Glassell Claes Executive Officer and Director   •       •      –    2007-02-28 4 B $5.41 $54,126 D/D 10,000 112,739 2.81     -
   Dawson William J Chief Financial Officer   •       –      –    2007-02-28 4 B $5.37 $108,670 D/D 20,000 53,195 2.74     -
   Greenman William Mariner President, Cerus Europe   •       –      –    2007-01-05 4/A A $0.00 $0 D/D 4,958 80,984     -
   Cook David N Vice President, R & D   •       –      –    2007-01-05 4 A $0.00 $0 D/D 5,970 43,836     -
   Ervin Howard G Vice President, Legal Affairs   •       –      –    2007-01-05 4 A $0.00 $0 D/D 5,432 37,241     -
  540 Records found
  Previous  20  21  22   
  Page 20 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us